Clicks Group Ltd

Healthcare US CLCGY

28.8USD
-0.5(1.71%)

Last update at 2026-06-03T19:58:00Z

Day Range

28.7729.19

LowHigh

52 Week Range

33.1043.37

LowHigh

Fundamentals

Previous Close 29.30
Market Cap4361.32M
Volume286
P/E Ratio22.47
Dividend Yield2.88%
EBITDA5275.64M
Revenue TTM47828.08M
Revenue Per Share TTM402.74
Gross Profit TTM 11399.65M
Diluted EPS TTM1.66

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2025-08-31	2024-08-31	2023-08-31	2022-08-31	2021-08-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-08-31	2024-08-31	2023-08-31	2022-08-31	2021-08-31
Income before tax	4322.95M	3893.81M	3471.11M	3639.15M	2641.82M
Minority interest	-	-	-	-	-
Net income	3155.69M	2837.06M	2537.53M	2638.68M	1837.86M
Selling general administrative	13.41M	13.04M	-	-	-
Selling and marketing expenses	424.35M	417.64M	-	-	-
Gross profit	12749.81M	10632.42M	9313.85M	8432.26M	7272.00M
Reconciled depreciation	-	1742.29M	1519.03M	1320.80M	1260.42M
Ebit	4561.94M	4248.85M	3718.73M	3650.41M	2896.86M
Ebitda	6397.02M	5991.14M	5237.76M	4750.18M	4196.06M
Depreciation and amortization	1835.08M	1742.29M	1519.03M	1099.77M	1299.20M
Non operating income net other	-	-	-	-	-
Operating income	4561.94M	4171.85M	3623.04M	3650.41M	2896.86M
Other operating expenses	45449.25M	41265.79M	37989.98M	34419.70M	34402.52M
Interest expense	354.89M	355.04M	231.58M	210.29M	220.26M
Tax provision	-	1056.75M	933.58M	1000.47M	727.72M
Interest income	-	89.87M	92.23M	45.45M	34.15M
Net interest income	-	-265.17200M	-139.35200M	-164.83500M	-186.11100M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	1167.26M	1056.75M	933.58M	1000.47M	727.72M
Total revenue	50011.19M	45437.64M	41621.68M	39587.14M	37339.03M
Total operating expenses	8187.87M	6460.57M	5682.15M	3264.82M	4335.49M
Cost of revenue	37261.38M	34805.22M	32307.83M	31154.88M	30067.03M
Total other income expense net	-238.98737M	-278.04400M	-151.93400M	-11.26700M	-255.03700M
Discontinued operations	-	-	-	-	-76.24500M
Net income from continuing ops	-	2837.06M	2537.53M	2638.68M	1914.10M
Net income applicable to common shares	-	-	-	2638.68M	1837.86M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2025-08-31	2024-08-31	2023-08-31	2022-08-31	2021-08-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-08-31	2024-08-31	2023-08-31	2022-08-31	2021-08-31
Total assets	22521.50M	20817.14M	19034.85M	17863.92M	17173.48M
Intangible assets	938.62M	946.36M	968.21M	720.99M	670.46M
Earning assets	-	-	-	-	-
Other current assets	232.65M	31.26M	-	3193.86M	3582.12M
Total liab	15685.28M	14531.60M	13070.04M	12165.11M	12368.29M
Total stockholder equity	6836.22M	6285.54M	5964.81M	5698.81M	4805.19M
Deferred long term liab	-	-	-	-	-
Other current liab	2897.33M	402.99M	444.31M	2744.76M	2228.40M
Common stock	2.35M	2.38M	2.41M	2.44M	2.46M
Capital stock	-	2.38M	2.41M	2.44M	2.46M
Retained earnings	5798.85M	-	-	4636.02M	3728.83M
Other liab	-	-	-	151.19M	196.93M
Good will	214.70M	209.11M	204.83M	102.81M	102.81M
Other assets	-	-	-	294.03M	268.84M
Cash	3245.62M	2704.96M	2455.18M	2014.55M	2206.63M
Cash and equivalents	-	-	-	-	-
Total current liabilities	12771.72M	11829.57M	10799.65M	9926.19M	10195.42M
Current deferred revenue	203.76M	-	-	-	-
Net debt	3484.14M	1081.33M	783.75M	1085.33M	716.29M
Short term debt	1330.00M	1249.59M	1086.44M	1012.16M	946.98M
Short long term debt	-	-	-	-	-
Short long term debt total	6729.77M	3786.29M	3238.93M	3099.88M	2922.91M
Other stockholder equity	1061.63M	6305.47M	5962.40M	5696.37M	4802.74M
Property plant equipment	-	-	-	5202.79M	4739.79M
Total current assets	14196.50M	12886.75M	11833.75M	11372.86M	11238.12M
Long term investments	-	-	-	-	-
Net tangible assets	-	-	-	4875.01M	4031.93M
Short term investments	-	-141.43600M	-	-	-
Net receivables	2923.89M	3087.24M	3019.49M	3081.62M	3368.73M
Long term debt	-	-	-	-	-
Inventory	7794.33M	7063.28M	6309.81M	6164.45M	5449.36M
Accounts payable	8340.64M	10030.90M	9268.90M	6169.28M	7020.04M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-26.62176M	-22.31500M	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	0.00002M	339.65M	315.22M	356.33M	316.10M
Deferred long term asset charges	-	-	-	-	-
Non current assets total	8325.00M	7930.39M	7201.11M	6491.05M	5935.37M
Capital lease obligations	-	3786.29M	3238.93M	3099.88M	2922.91M
Long term debt total	-	-	-	-	-

Breakdown	2025-08-31	2024-08-31	2023-08-31	2022-08-31	2021-08-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-08-31	2024-08-31	2023-08-31	2022-08-31	2021-08-31
Investments	-	-913.89900M	-1210.93400M	-8.71500M	-19.00000M
Change to liabilities	-	-	-	-396.17300M	1972.69M
Total cashflows from investing activities	-937.55749M	-913.89900M	-	-784.01500M	-718.40800M
Net borrowings	-	-	-	-879.53700M	-786.86500M
Total cash from financing activities	-3635.99051M	-1842.46000M	-1658.51600M	-1325.13400M	-1539.17500M
Change to operating activities	-	-	-	-62.36600M	4.62M
Net income	3155.69M	3893.81M	3471.11M	3639.15M	2535.61M
Change in cash	558.39M	249.78M	440.62M	-192.07400M	54.14M
Begin period cash flow	2687.23M	2455.18M	2014.55M	2206.63M	2152.48M
End period cash flow	3245.62M	2704.96M	2455.18M	2014.55M	2206.63M
Total cash from operating activities	5110.63M	3006.14M	3310.07M	1917.08M	2311.73M
Issuance of capital stock	-	-	-	-	-
Depreciation	1835.08M	1742.29M	1519.03M	1374.61M	1260.42M
Other cashflows from investing activities	23.06M	-8.59600M	-	60.09M	-11.00800M
Dividends paid	1863.72M	1675.96M	-	1286.94M	1468.90M
Change to inventory	-734.71929M	-755.84900M	-127.16500M	-711.96100M	-529.64400M
Change to account receivables	-80.18476M	-54.53000M	-	426.03M	-905.85900M
Sale purchase of stock	-732.70769M	-834.79000M	-703.52000M	-445.59700M	-752.31000M
Other cashflows from financing activities	-1039.56458M	1675.96M	-954.99600M	-879.53700M	-786.86500M
Change to netincome	-	-	-	-64.80900M	168.85M
Capital expenditures	959.99M	890.86M	930.00M	837.60M	689.74M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	71.03M	99.36M	672.81M	-744.46600M	541.81M
Stock based compensation	-	-	-	-	-
Other non cash items	48.83M	-2729.31400M	-2352.86900M	-2352.21700M	-2026.11400M
Free cash flow	4150.64M	2115.28M	2380.07M	1079.48M	1621.99M

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
CLCGY Clicks Group Ltd	-0.5 1.71%	28.80	22.47	31.85	0.09	10.04	1.47	10.53
ALBHF Alibaba Health Information Technology Limited	- -%	0.48	36.00	19.01	0.36	3.63	1.73	25.72
RADLY Raia Drogasil SA ADR	-0.18 4.90%	3.49	47.15	32.68	0.34	9.83	0.35	3.29
ALBBY Alibaba Health Information Technology Limited	0.27 2.85%	9.75	34.43	19.84	0.29	3.79	1.73	25.72
SHPPF Shop Apotheke Europe N.V	- -%	45.18	-	-	2.80	2.28	1.70	78.78

Reports Covered

View All

Profile

Clicks Group Limited, together with its subsidiaries, operates as a health, wellness, and beauty retailer in South Africa and internationally. The company operates through two segments, Retail and Distribution. It provides retail, including Clicks, a specialist health, beauty and homeware retailer; Sorbet, a franchise of hair and beauty salons; 180 Degrees Marketing, a software development company; and The Body shop, which specializes in naturally inspired luxury toiletries, cosmetics, gifting and grooming, with stores. The company also offers various ranges of mother-and-baby products, including baby hardware, accessories, health, food, diaper and wipes, and baby toiletries under the Clicks Baby brand; and diabetic clinic, travel clinic, and wound management practice under the M-KEM brand. In addition, the company is involved in the wholesale and supply of pharmaceutical products to retail pharmacies, private hospitals, dispensing doctors, and retail health stores under the UPD brand. The company was formerly known as New Clicks Holdings Limited and changed its name to Clicks Group Limited in June 2009. Clicks Group Limited was founded in 1968 and is headquartered in Cape Town, South Africa.

Clicks Group Ltd

Cnr. Searle and Pontac Streets, Cape Town, South Africa, 8000

27 21 460 1911
https://www.clicksgroup.co.za
Employees : 20102

Key Executives

Name	Title	Year Born
Ms. Bertina D. Engelbrecht B.Proc, LLM	CEO & Exec. Director	1963
Mr. Michael Fleming B.Com., C.A., CA (SA)	CFO & Exec. Director	1967
Mr. Matthew Welz LLB	Group Head of Legal Counsel & Company Sec.	NA
Mr. Christopher Tugman	Group Head of Information Technology	1968
Ms. Rachel Wrigglesworth	Chief Commercial Officer	1965
Mr. Gordon Traill	Chief Support Services Officer	1971
Ms. Nina Hind	Head of Retail Fin.	1974
Ms. Bertina D. Engelbrecht B.Proc, LLM	CEO & Executive Director	1963
Mr. Gordon D. Traill	CFO, Chief Support Services Officer & Director	1971
Ms. Nina Hind	Head of Retail Finance	1974

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.